Prestige Consumer Healthcare (PBH) Cash from Financing Activities (2010 - 2025)

Prestige Consumer Healthcare's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at -$6.7 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 87.5% year-over-year to -$6.7 million; the TTM figure through Dec 2025 stood at -$129.5 million (up 45.84% YoY), while the FY2025 annual figure was -$182.1 million, up 24.45% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at -$6.7 million, up from -$74.9 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $63.6 million in Q2 2021, with the low at -$83.7 million in Q1 2021.
• The 5-year median for Cash from Financing Activities is -$53.7 million (2023), against an average of -$40.9 million.
• Peak annual rise in Cash from Financing Activities reached 167.11% in 2021, while the deepest fall reached 647.88% in 2021.
• Prestige Consumer Healthcare's Cash from Financing Activities stood at -$67.6 million in 2021, then surged by 85.18% to -$10.0 million in 2022, then tumbled by 547.07% to -$64.8 million in 2023, then advanced by 16.93% to -$53.9 million in 2024, then soared by 87.5% to -$6.7 million in 2025.
• Business Quant data shows PBH's Cash from Financing Activities at -$6.7 million in Q4 2025, -$74.9 million in Q3 2025, and -$36.3 million in Q2 2025.